cardiovascular-agents and Mucositis

cardiovascular-agents has been researched along with Mucositis* in 1 studies

Other Studies

1 other study(ies) available for cardiovascular-agents and Mucositis

Article	Year
The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:2 To examine the association of xerogenic medications with the oral mucosa inflammation score (OMS) in US male veterans.. The relationship of having the worst 25th percentile in OMS and intake of xerogenic medications with different pharmacologic indications was analyzed by logistic regression, controlling for age in 3 categories (< or =44, 45-64, > or =65), smoking, disease burden index, alcohol abuse, and the duration of medication, in 290 subjects participating in the Veterans Dental Study.. When polypharmacy and denture-wearing status in addition to the aforementioned covariates were controlled, the odds ratios for cardiovascular disease medications and sympathetic agonists were 2.82 (95% confidence interval [CI] 1.35-5.91, P < .006), and 2.96 (CI 1.21-7.26, P < .02), respectively, and those for psychotropics and antihistamines were 2.12 (CI 0.94-4.80, P < .06) and 2.09 (CI 0.80-5.48, P < 0.14), respectively.. Xerogenic medication may be associated with oral mucosal pathology. Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Confounding Factors, Epidemiologic; Histamine H1 Antagonists; Humans; Logistic Models; Male; Middle Aged; Mouth Mucosa; Mucositis; Odds Ratio; Psychotropic Drugs; Retrospective Studies; Stomatitis; Sympathomimetics; United States; Veterans; Xerostomia	2007

Article

Year

The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:2

To examine the association of xerogenic medications with the oral mucosa inflammation score (OMS) in US male veterans.. The relationship of having the worst 25th percentile in OMS and intake of xerogenic medications with different pharmacologic indications was analyzed by logistic regression, controlling for age in 3 categories (< or =44, 45-64, > or =65), smoking, disease burden index, alcohol abuse, and the duration of medication, in 290 subjects participating in the Veterans Dental Study.. When polypharmacy and denture-wearing status in addition to the aforementioned covariates were controlled, the odds ratios for cardiovascular disease medications and sympathetic agonists were 2.82 (95% confidence interval [CI] 1.35-5.91, P < .006), and 2.96 (CI 1.21-7.26, P < .02), respectively, and those for psychotropics and antihistamines were 2.12 (CI 0.94-4.80, P < .06) and 2.09 (CI 0.80-5.48, P < 0.14), respectively.. Xerogenic medication may be associated with oral mucosal pathology.

Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Confounding Factors, Epidemiologic; Histamine H1 Antagonists; Humans; Logistic Models; Male; Middle Aged; Mouth Mucosa; Mucositis; Odds Ratio; Psychotropic Drugs; Retrospective Studies; Stomatitis; Sympathomimetics; United States; Veterans; Xerostomia

2007